Clinical Trial Core

Information

  • Research Project
  • 9037575
  • ApplicationId
    9037575
  • Core Project Number
    U19AI100266
  • Full Project Number
    5U19AI100266-05
  • Serial Number
    100266
  • FOA Number
    RFA-AI-11-013
  • Sub Project Id
    7987
  • Project Start Date
    -
  • Project End Date
    -
  • Program Officer Name
  • Budget Start Date
    4/1/2016 - 10 years ago
  • Budget End Date
    3/31/2017 - 9 years ago
  • Fiscal Year
    2016
  • Support Year
    05
  • Suffix
  • Award Notice Date
    3/31/2016 - 10 years ago
Organizations

Clinical Trial Core

PROJECT SUMMARY The long-term objective of the Clinical Trial Core will be to facilitate the Scientific Objectives, Aims and Goals of the Center by supporting/undertaking two prospective clinical trials and ensuring that these activities are performed in compliance with ICH/GCP Guidelines, Health Canada and local IRB regulatory requirements. In Project 1 a randomized, double-blind, placebo-controlled trial of peptide immunotherapy will be performed in 48 subjects with cat-allergic rhinitis in order to obtain peripheral blood samples from which allergen-specific T cells will be enrich and characterized to determine their frequency and functional phenotype before, immediately after, and 1 year after, peptide immunotherapy. In Project 2 a total of 48 cat-allergic asthmatic subjects will be subjected to segmental lung allergen challenge (with saline control segment). Peripheral blood and bone marrow will be taken before and after the lung challenge and bronchoalveolar lavage will be performed on saline- and allergen-challenged lobes 24 hours post-challenge. Allergen-specific T cells will be enriched and characterized from each compartment. The Specific Aims of Clinical Trial Core B will be; Aim 1: to provide clinical oversight and resources (personnel, equipment and knowledge). Aim 2: to ensure recruitment of adequate numbers of well characterized study subjects. Aim 3: to ensure the safety of all study participants by monitoring compliance with ICH/GCP and providing expert medical surveillance. Aim 4: to provide clinical expertise to facilitate the collection of standardized, high quality clinical samples required to support the scientific aims, and fulfill the goals, of the Center. Aim 5: to liaise with Administrative Core A to complete and manage all of the required regulatory documents (including local Research Ethics Board/Institutional Review Board; REB/IRB) and to facilitate communication of clinical issues between the Center, the REB/IRB, the Scientific Advisory Panel (SAP) and NIH Program staff.

IC Name
NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES
  • Activity
    U19
  • Administering IC
    AI
  • Application Type
    5
  • Direct Cost Amount
    17097
  • Indirect Cost Amount
    1360
  • Total Cost
  • Sub Project Total Cost
    18457
  • ARRA Funded
    False
  • CFDA Code
  • Ed Inst. Type
  • Funding ICs
    NIAID:18457\
  • Funding Mechanism
    Non-SBIR/STTR RPGs
  • Study Section
    ZAI1
  • Study Section Name
    Special Emphasis Panel
  • Organization Name
    MCMASTER UNIVERSITY
  • Organization Department
  • Organization DUNS
    207510108
  • Organization City
    HAMILTON
  • Organization State
    ON
  • Organization Country
    CANADA
  • Organization Zip Code
    L8S 4K1
  • Organization District
    CANADA